Incyte Corporation
INCY Stock News
Latest INCY news
Incyte Data at the European Academy of Dermatology and Venereology (EADV) Congress Underscore the Breadth of Incyte's Inflammation and Autoimmunity Portfolio
Business Wire · Tue, 22 Sep 2026 08:30:00 -0400
WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY--Incyte Data at the 2026 EADV Congress Underscore the Breadth of Incyte's Inflammation and Autoimmunity Portfolio.
Is First Trust Large Cap Growth AlphaDEX ETF (FTC) a Strong ETF Right Now?
Zacks Investment Research · Tue, 22 Sep 2026 07:21:15 -0400
The First Trust Large Cap Growth AlphaDEX ETF (FTC) was launched on 05/08/2007, and is a smart beta exchange traded fund designed to offer broad exposure to the Style Box - Large Cap Growth category of the market.
Incyte Maps Post-JAKAFI Growth With Pipeline Push and $4B Sales Target
MarketBeat · Sat, 19 Sep 2026 22:02:09 -0400
Incyte NASDAQ: INCY executives outlined a strategy centered on expanding its non-JAKAFI business, advancing a broader late-stage pipeline and preparing for the loss of exclusivity for JAKAFI after 2029.
Incyte Corporation (INCY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha · Wed, 16 Sep 2026 16:01:38 -0400
Incyte Corporation (INCY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Zacks Investment Research · Wed, 16 Sep 2026 09:56:06 -0400
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
INCY Stock Gains 23% Year to Date: Buy, Sell or Hold?
Zacks Investment Research · Mon, 14 Sep 2026 16:21:09 -0400
Incyte's strong product demand and pipeline progress fuel its 23% YTD rally, but valuation and near-term earnings pressure temper the outlook.
Profitable Biotech Incyte Forms Handle As Institutional Buyers Load Up On Stock
Investors Business Daily · Fri, 11 Sep 2026 08:00:27 -0400
Incyte stock is trading just below a buy zone as Big Money gives it the stamp of approval.
Market information is provided for research and visualization and is not investment advice.